{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:21Z","timestamp":1792519041531,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.amjms.2022.02.014","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T01:52:34Z","timestamp":1652061154000},"page":"529-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy"],"prefix":"10.1016","volume":"364","author":[{"given":"Antonietta","family":"Gigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Leodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2022.02.014_bib0001","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0002","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.amjms.2022.02.014_bib0003","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009740802629424","article-title":"Renal function is mostly preserved in patients with systemic sclerosis","volume":"38","author":"Scheja","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.amjms.2022.02.014_bib0004","article-title":"Immunological basis of systemic sclerosis","volume":"45","author":"Zuber","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0005","first-page":"243","article-title":"Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma)","volume":"91","author":"Lapenas","year":"1978","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0007","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","article-title":"Renal vascular histology and morphometry in systemic sclerosis. a case\u2013control autopsy study","volume":"31","author":"Trostle","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2397198318758607","article-title":"Kidney involvement in systemic sclerosis: From pathogenesis to treatment","volume":"3","author":"Bruni","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.amjms.2022.02.014_bib0009","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.61.8.682","article-title":"Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement","volume":"61","author":"Livi","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2022.02.014_bib0010","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0011","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: A retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjms.2022.02.014_bib0012","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2022.02.014_bib0013","article-title":"Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases)","author":"Ponticelli","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0014","doi-asserted-by":"crossref","first-page":"e4459","DOI":"10.1097\/MD.0000000000004459","article-title":"Complement activation and effect of eculizumab in scleroderma renal crisis","volume":"95","author":"Devresse","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Okr\u00f3j","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.amjms.2022.02.014_bib0017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005792-198311000-00001","article-title":"Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis","volume":"62","author":"Traub","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0018","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2022.02.014_bib0019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","article-title":"EUSTAR collaborators. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis","volume":"22","author":"B\u00fctikofer","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.amjms.2022.02.014_bib0020","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1093\/ndt\/gfs317","article-title":"Prognosis of scleroderma renal crisis: a long-term observational study","volume":"27","author":"Cozzi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjms.2022.02.014_bib0021","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0022","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/rheumatology\/kez435","article-title":"Classifications of scleroderma renal crisis and reconsideration of its pathophysiology","volume":"58","author":"Yamashita","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0023","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0024","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/S0272-6386(99)70244-1","article-title":"MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease?","volume":"33","author":"Anders","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjms.2022.02.014_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5414\/CNP70183","article-title":"Noncrescentic ANCA-associated renal crisis in systemic sclerosis","volume":"70","author":"Mimura","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0026","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2010.11.001","article-title":"Anti-neutrophil antibody associated vasculitis in systemic sclerosis","volume":"41","author":"Arad","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780390622","article-title":"Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy","volume":"39","author":"Rivolta","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0028","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijcard.2014.08.122","article-title":"Autonomic dysfunction in patients with systemic sclerosis: correlation with intrarenal arterial stiffness","volume":"177","author":"Gigante","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0029","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.semarthrit.2011.11.005","article-title":"Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis","volume":"41","author":"Rosato","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/03009742.2012.723748","article-title":"Doppler indices of intrarenal arterial stiffness are useful in monitoring scleroderma renal crisis","volume":"42","author":"Rosato","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0031","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/acr.22309","article-title":"Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis","volume":"66","author":"Rosato","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0032","first-page":"1944","article-title":"Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis","volume":"24","author":"Scorza","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0033","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/aps.2009.128","article-title":"N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis","volume":"30","author":"Rosato","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.amjms.2022.02.014_bib0034","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000442996","article-title":"Left ventricular mass and intrarenal arterial stiffness as early diagnostic markers in cardiorenal syndrome type 5 due to systemic sclerosis","volume":"6","author":"Gigante","year":"2015","journal-title":"Cardio Renal Med"},{"key":"10.1016\/j.amjms.2022.02.014_bib0035","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s10067-020-05141-0","article-title":"Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients","volume":"39","author":"Rosato","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0036","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","article-title":"Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment","volume":"42","author":"Kingdon","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjms.2022.02.014_bib0037","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-010-1389-3","article-title":"Renal disease in systemic sclerosis with normal serum creatinine","volume":"29","author":"Mohamed","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0038","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0039","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/rheumatology\/kes049","article-title":"Evaluation of chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in scleroderma patients","volume":"51","author":"Gigante","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjms.2022.02.014_bib0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.amjms.2016.04.017","article-title":"Correlation of glomerular filtration rate between renal scan and estimation equation for patients with scleroderma","volume":"352","author":"Suebmee","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2022.02.014_bib0041","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.amjms.2022.02.014_bib0042","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.ki.5002755","article-title":"Age- and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: Results of the Nijmegen Biomedical Study","volume":"73","author":"Wetzels","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjms.2022.02.014_bib0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2022.02.014_bib0044","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2022.02.014_bib0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5414\/CNP70110","article-title":"Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity","volume":"70","author":"Seiberlich","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0046","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2022.02.014_bib0047","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ki.2013.359","article-title":"Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney","volume":"85","author":"Wang","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjms.2022.02.014_bib0048","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3899\/jrheum.190165","article-title":"Renal parenchymal thickness in patients with systemic sclerosis is related to intrarenal hemodynamic variables and raynaud renal phenomenon","volume":"47","author":"Gigante","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0049","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000489740","article-title":"Prognostic factors of renal involvement in systemic sclerosis","volume":"43","author":"Rosato","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjms.2022.02.014_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2019.09.001","article-title":"The Renal Resistive Index in systemic sclerosis: determinants, prognostic implication and proposal for specific age-adjusted cut-offs","volume":"70","author":"Bruni","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjms.2022.02.014_bib0051","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000505659","article-title":"Late Gadolinium Enhancement in Cardiac Magnetic Resonance Imaging Is Associated with High Renal Resistive Index in Patients with Systemic Sclerosis","volume":"45","author":"Cianci","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjms.2022.02.014_bib0052","article-title":"The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis","author":"Gigante","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0053","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/anr.1780321011","article-title":"Activation of the complement system in systemic sclerosis. Relationship to clinical severity","volume":"32","author":"Senaldi","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2022.02.014_bib0054","first-page":"1379","article-title":"Eculizumab in atypical hemolytic-uremic syndrome","volume":"369","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2022.02.014_bib0055","article-title":"Scleroderma renal crisis debute with thrombotic microangiopathy: a successful case treated with eculizumab","author":"Uriarte","year":"2018","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.amjms.2022.02.014_bib0056","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2022.02.014_bib0057","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mvr.2016.03.007","article-title":"Serum uric acid as a marker of microvascular damage in systemic sclerosis patients","volume":"106","author":"Gigante","year":"2016","journal-title":"Microvasc Res"},{"key":"10.1016\/j.amjms.2022.02.014_bib0058","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.amjms.2022.02.014_bib0059","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mvr.2017.06.003","article-title":"Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy","volume":"114","author":"Gigante","year":"2017","journal-title":"Microvascular Res"},{"key":"10.1016\/j.amjms.2022.02.014_bib0060","article-title":"Renal parenchymal thickness is both related to vascular endothelial growth factor and intrarenal stiffness in systemic sclerosis","volume":"38","author":"Villa","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922002208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922002208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:41:55Z","timestamp":1757702515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922002208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0002962922002208"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.02.014","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}